ISTH 2020 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB2486

E-selectin Inhibitor Is Superior to LMWH for Treatment of Experimental Venous Thrombosis

D. Myers, Jr¹, J.-J. Ning², P. Lester¹, R. Adili¹, A. Hawley¹, L. Durham¹, V. Dunivant¹, G. Reynolds¹, K. Crego¹, S. Sood¹, R. Sigler¹, W. Fogler³, J. Magnani³, M. Holinstat¹, T. Wakefield¹
Abstract Number: PB0152

Early Indicators of Thromboembolic Events Caused by Prolonged Tourniquet Application: A Rat Model

J. Chung^1,2, O. Mian^2,3, A. Chan^2,4, D. Matino^2,4
Abstract Number: PB2437

Early Physiotherapy Intervention Reduces the Long Term Effects of Venous Thromboembolism and Promotes an Improved Quality of Life: Results from a Pilot Study

R. Lewis¹, C. Entwistle¹, M. Robinson²
Abstract Number: PB2536

Early Plasma Transfusion and Maternal Outcomes in Women with Persistent Postpartum Haemorrhage: Does the Amount of Resuscitation Fluids Matter?

C. Caram-Deelder¹, D. Henriquez², S. le Cessie², J. Zwart³, J. van Roosmalen⁴, H. Eikenboom², C. So-Osman⁵, L. van de Watering⁵, J.J. Zwaginga², A. Koopman-van Gemert⁶, K. Bloemenkamp², J.G. van der Bom¹, TeMpOH-1
Abstract Number: PB1170

Economic Burden Associated with Vaso-Occlusive Crisis Management in Patients with Sickle Cell Disease

A. Oladapo¹, E. Swallow², A. Briggs², M.L. Zichlin², B. Mellgård¹
Abstract Number: PB2407

Edoxaban for the Long-Term Therapy of Venous Thromboembolism in Real-Life RIETE Registry

G. Camporese¹, P. Simioni², P. Di Micco³, C. Fernández-Capitán⁴, A. Rivas⁵, C. Font⁶, J.C. Sahuquillo⁷, P. Villares⁸, P. Prandoni¹, M. Monreal⁹
Abstract Number: PB2409

Edoxaban Treatment of Venous Thromboembolism in Routine Clinical Practice in the Non-Interventional Global ETNA-VTE Program: A Sub-Analysis by Age Groups

G. Agnelli¹, M. Nakamura², K.-M. Chiu^3,4, W.-I. Choi⁵, P. Reimitz⁶, C. Chen⁷, M. Unverdorben⁷, A. Cohen⁸
Abstract Number: PB0554

Effect of Activated Charcoal in Removing Interference in Thrombophilia Assays: Resistance to Activated Protein C, Activity of Coagulation Factor VIII and Antithrombin Activity

S. Margetić¹, I. Ćelap¹, S. Šupraha-Goreta², J. Buben³, R. Mihić¹
Abstract Number: PB0549

Effect of Antiepileptic Therapy on Platelet Aggregation

I. Ćelap, S. Margetić, R. Mihić
Abstract Number: PB2395

Effect of Antiplatelet Therapy on Clinical Outcome of Patients Treated with Anticoagulation for Acute Venous Thromboembolism

A.I. Casanegra¹, R.D. McBane¹, D.T. Vlazny¹, D.E. Houghton¹, D.O. Hodge², D.A. Froehling¹, L.G. Peterson¹, W.E. Wysokinski¹
Abstract Number: PB0762

Effect of B-Mode Ultrasound-Guided Pulsed – High Intensity Focused Ultrasound-Mediated Inertial Cavitation Thrombolytic Therapy Accompanied by Air-Contained Sonicated Dextrose Albumin Microbubbles Administration on Embolic Artery Occlusion

H. Mehrad¹, M. Farhoudi²
Abstract Number: PB0044

Effect of BTK Inhibition on Platelet-mediated Inflammation in an Obese Rhesus Macaque Model of Early Atherosclerosis

T. Kohs¹, S. Olson², A. Xie², J. Hodovan², M. Muller², C. McArthur², J. Johnson², M. Wallisch², C. Lorentz², N. Verbout², P. Kievit², J. Aslan², O. McCarty², J. Lindner², J. Shatzel²
Abstract Number: PB1819

Effect of cART on Platelet:Lymphocyte Ratio in HIV Patients Initiating Treatment

H. Omunakwe^1,2, B. Moore-Igwe³, O. Maduka^4,5, E.M. Eze³, S.G. Christian³
Abstract Number: PB0510

Effect of Dabigatran versus Enoxaparin on Blood Coagulation using the Viscoelastic Coagulation Test

V.M. Silva¹, C. Cavalheiro², C.C. Strunz¹
Abstract Number: PB1221

Effect of Foot Bath on the Plasma Concentration of Plasminogen Activator Inhibitor-1 Produced by Endothelial Cells in Healthy Subjects

T. Hayashi¹, A. Tamada²
Abstract Number: PB1839

Effect of Human Myeloperoxidase on Ca²⁺-response, Membrane Conductivity and Phosphatidylserine Exposure on Platelet Surface

E. Shamova¹, A. Kokhan¹, I. Gorudko¹, D. Grigorieva¹, F. Balabin², A. Sokolov^3,4, A. Sveshnikova²
Abstract Number: PB1897

Effect of Immune-Purified aβ2-Glycoprotein I (aβ2GPI) and Anti Phosphatidylserine/Prothrombin (aPS/PT) Antibodies on Thrombin Generation

E. Bison, E. Pontara, M. Cattini, C.-Y. Cheng, G. Denas, V. Pengo
Abstract Number: PB0217

Effect of Mg(II) Ion on the Interaction of Coagulation Factors with Phospholipid Membranes

Y. Shikamoto¹, T. Morita², H. Mizuno³, K. Mori¹
Abstract Number: PB1113

Effect of Oral Anticoagulant Use on Surgical Delay and Outcomes in Hip Fracture Patients: A Systematic Review and Meta-Analysis

Y. Xu¹, D. You², B. Ponich², H. Krzyzaniak², P. Ronksley², L. Skeith², P. Schneider², M. Carrier¹
Abstract Number: PB2054

Effect of Patient and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) Study

K. MacDougall¹, J. Douketis², N. Li², N. Clark³, A. Tafur⁴, J. D'Astous⁵, J. Duncan², S. Schulman², A. Spyropoulos⁶
Abstract Number: PB0025

Effect of Phosphomimetic Endothelial Nitric Oxide Synthase – Loaded Microbubbles-Mediated Transfection Therapy using B-Mode Ultrasound-Guided Focused – Low Level Confocal Dual-Pulse Electrohydraulic Shock Waves on Early Stage Atherosclerosis

H. Mehrad¹, A. Foletti²
Abstract Number: PB0045

Effect of Photobiomodulation Therapy on Arterial Biomechanical Parameters in a Rabbit Carotid Artery Model of Early Stage Atherosclerosis

H. Mehrad¹, L. Kazemi²
Abstract Number: PB0046

Effect of Photodynamic Therapy on Arterial Biomechanical Parameters in a Rabbit Carotid Artery Model of Neointimal Hyperplasia

H. Mehrad¹, A. Najafzadeh²
Abstract Number: PB0097

Effect of Pulsatility on Thrombosis Modelling in Cerebral Aneurysms

S. Hume^1,2, I. Tshimanga³, W.-H. Ho⁴, M. Ngoepe⁵
Abstract Number: PB1116

Effect of rFVIIa on Thromboelastogram Parameters in Haemophilia A Patients with Inhibitor

V. Krasivska¹, O. Stasyshyn², M. Semerak², O. Tushnytskyi³
Abstract Number: PB0763

Effect of Streptokinase-Loaded Microbubbles-Mediated B-Mode Ultrasound-Guided Sono-Photomechanic Combination Thrombolytic Therapy on Atherothrombotic Stenosis

H. Mehrad¹, M. Farhoudi²
Abstract Number: PB1430

Effect of Synthetic Inhibitors on HIT Antigenic Complex – Therapeutic Approach Alternative to Anticoagulation

J.N. Kizhakkedathu¹, C. La², M.T. Kalathottukaren³, S.V. Yarovoi⁴, V. Hayes⁵, G.T. Koma⁵, S. Abbina¹, J.H. Morrissey⁶, C.A. Haynes⁷, D.B. Cines⁴, L. Rauova^5,8
Abstract Number: PB0807

Effect of the First Factor VIII Infusions on Immunological Biomarkers in Children with Hemophilia A: Results from the HEMFIL Study

L. Lemos Jardim^1,2, L. Maira Moura de Oliveira¹, M. Portugal Santana³, M. Hermida Cerqueira⁴, C. Santos Lorenzato⁵, V. Karla Brognoli Franco⁶, L. Werneck Zuccherato¹, S. Meireles Rezende¹, D. Gonçalves Chaves³
Abstract Number: PB1636

Effect of Three Types of Mixed Anesthesia (MMB) for Platelet Function

T. Kano, Y. Suganuma, K. Ikemoto, C. Ichinose, T. Matsui, K. Kondo
Abstract Number: PB0581

Effect of Vitamin K Antagonist Therapy on the Dynamics of Hypercoagulation Syndrome in Patients with Deep Vein Thrombosis

N. Vorobyeva, A. Alexseeva
Abstract Number: PB0351

Effect of Warfarin Addition in Diabetic Foot Ulcer Patients Receiving Cilostazol In Mohammad Hoesin Hospital, South Sumatera, Indonesia

M. Syahrir, E.S. Maksudin, Y. Tanta, A. Shahab
Abstract Number: PB2412

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in a Large Daily Practice Cohort

S.V. Hendriks^1,2, F.A. Klok¹, W.J.E. Stenger¹, A.T.A. Mairuhu², J. Eikenboom¹, J. Fogteloo³, M.V. Huisman¹
Abstract Number: PB2166

Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Ph-negative Myeloproliferative Neoplasms and Venous Thromboembolism

V. De Stefano¹, S. Betti², T. Za¹, A. Ciminello¹, F. Bartolomei¹, S. Ceglie¹, F. Ramundo¹, F. Di Landro¹, P. Chiusolo¹, E. Rossi¹, T. Barbui³
Abstract Number: PB2113

Effectiveness and Safety of Enoxaparin in Patients with Active Cancer and Venous Thromboembolism (VTE): A Systematic Literature Review

J. Shan¹, T. Sayre², K. Hofer³, E.T. Shojaei³
Abstract Number: PB1310

Effectiveness and Safety of Primary Thromboprophylaxis in Pediatric Renal Transplant: a Systematic Review of the Literature and Meta-Analysis

A. Al-Huniti, C. Malcolmson, C.W. Toeh, V. Langlois, A. Lorenzo, S. Williams, L. Brandao
Abstract Number: PB2211

Effectiveness and Safety of Pulmonary Rehabilitation to Reduce Functional Impairment Based on the Post-PE Syndrome

G.J.A.M. Boon¹, S.M.J. Janssen², S. Barco^3,4, H.J. Bogaard⁵, W. Ghanima⁶, L.J.M. Kroft⁷, L.J. Meijboom⁸, M.K. Ninaber⁹, E.J. Nossent¹⁰, P. Symersky¹¹, H.W. Vliegen¹², A. Vonk Noordegraaf¹⁰, M.V. Huisman¹, B. Siegerink^13,14, J.J. Abbink², F.A. Klok¹
Abstract Number: PB2171

Effectiveness and Safety of Rivaroxaban in Patients with Cancer-associated Venous Thromboembolism

O.S. Costa^1,2, C.G. Kohn^2,3, G.H. Lyman⁴, N.M. Kuderer⁵, T.J. Bunz⁶, C.I. Coleman^1,2
Abstract Number: PB1226

Effectiveness of a Self-management Program in the Treatment Control of Oral Anticoagulants Antivitamin K

A. Vall¹, M. Constans¹, A. Altes¹, R. Santiago², C. Motllo², R. López²
Abstract Number: PB2382

Effectiveness of Implementing a Prophylaxis Protocol for Thromboembolic Events in Patients Admitted to a Tertiary Hospital

M. Amorim de Oliveira, A. Haddad, C. Ferraz, A. Cerqueira, A. Godomiczer, C. Carvalho, A.L. Cascardo Marins, L.E. Carpenter
Abstract Number: PB2384

Effectiveness of Thromboprophylaxis in the Prevention of Peripherally Inserted Central Catheter (PICC) Associated Venous Thromboembolism in Pediatric Patients: A Case-control Study

M. Speckert^1,2, S. Lamontagne¹, K. Tang³, E. Simpson^1,2
Abstract Number: PB0669

Effects of Anticoagulants and Common Interfering Substances on Four Commercially Available dRVVT Assays

A. Sadeghi-Khomami¹, D. Lamont², M. Boylan², R. Clarke², N. Kesavan², C. Douglas², K. Black²
Abstract Number: PB0181

Effects of Anticoagulants on Fibrin Clot Structure: A Comparison between Vitamin K Antagonists and FXa inhibitors

J. S. Gauer¹, E. Page¹, N. Riva², A. Gatt², H. Philippou¹, M. Makris³, R.A.S. Ariens¹
Abstract Number: PB2200

Effects of Body Mass Index on the Human Plasma Proteome – Potential Drivers of Obesity-related Cardiovascular Disease?

L. Goudswaard^1,2,3, J.A. Bell^2,3, D.M. Hughes³, K. Walter⁴, N. Soranzo⁴, A. Adam Butterworth⁵, I. Hers¹, N.J. Timpson^2,3
Abstract Number: PB0371

Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Advanced Colorectal Cancer Patients

L. Traby, H.C. Puhr, M. Kollars, O. Steinbrecher, G. Prager, W. Scheithauer, G. Kornek, P.A. Kyrle, S. Eichinger
Abstract Number: PB1660

Effects of GPVI on Clot Structure: Reduction in Procoagulant Platelets in GPVI-Deficient Clots

J. S. Gauer¹, C. Duval¹, S. Baker^1,2, R.-G. Xu¹, A. Slater³, E. Martin³, S.P. Watson³, R.A.S. Ariëns¹
Abstract Number: PB0150

Effects of Hibernation on the Platelet Proteome of 13-lined Ground Squirrels

S. Cooper¹, J. Cunliffe², P. Wilmarth², L. David², J. Aslan²
Abstract Number: PB0716

Effects of Lysine-Containing Peptides Treatment on FXIII Activity and Fibrinogen Level of Metabolic Disorders

T. Shubina, T. Obergan
Abstract Number: PB0254

Effects of Plasmin on Factor XII Structure and Activation

I. Ivanov, A. Shamanaev, M.-F. Sun, D. Gailani
Abstract Number: PB0572

Effects of Rivaroxaban on Thrombophilia Screening Tests – Results from a UK NEQAS (Blood Coagulation) Exercise

I. Jennings, S. Kitchen, D. Kitchen, S. Munroe-Peart, A. Lowe, L. Brown, I. Walker
Abstract Number: PB0707

Effects of Squalene-Adenosine Nanoparticles on Platelet Aggregation, Thrombin Generation and Endothelial Cells

V. Maloteau¹, M. Vandeputte¹, M. Varna², P. Couvreur², J.-M. Dogné^1,3, J. Laloy^1,3
Abstract Number: PB1817

Effects of the Bacterial Toxin Cytotoxic Necrotising Factor 1 on Platelet Function

A. Chacko¹, D. Riley¹, J. Wei², A. Colarusso³, M.L. Tutino³, F. Rivero¹
Abstract Number: PB0930

Efficacy and Safety of a 21-Day Individualized Dosing Interval in Patients with Hemophilia B Treated with rIX-FP

E. Santagostino¹, T. Lissitchkov², A. Nagao³, A. Lubetsky⁴, L.M. Lepatan⁵, K. Nogami⁶, W. Seifert⁷, Y. Li⁸, I. Pabinger⁹
Abstract Number: PB0876

Efficacy and Safety of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients with Severe or Moderately Severe Hemophilia A: Results from a Phase 4 Study

Y. Zhao¹, Y. Hu², J. Jin³, X. Zhao⁴, X. Wang⁵, R. Wu⁶, D. Wu⁷, R. Yang⁸, F. Yang⁹, Q. Hu¹⁰, J. Wang¹¹, H. Fang¹², W. Engl¹³
Abstract Number: PB2378

Efficacy and Safety of Apixaban for the Primary Prevention of VTE among Patients with Gastrointestinal Cancers: A Post-hoc Analysis of the AVERT Trial

D. Ladha, R. Mallick, P. Wells, M. Carrier
Abstract Number: PB0916

Efficacy and Safety of BAY 94-9027 Prophylaxis for ≥5 Years: Outcomes in 36 Patients from the PROTECT VIII Extension Study

P.A. Holme¹, R. Klamroth², W. Miesbach³, M. Wang⁴, M.E. Mancuso⁵, M.T. Reding⁶
Abstract Number: PB0302

Efficacy and Safety of Ciraparantag in Reversing Apixaban and Rivaroxaban as Measured by Whole Blood Clotting Time in Healthy Adults

J. Ansell¹, S. Bakhru², S. Villano³, X. Luo³
Abstract Number: OC 12.1

Efficacy and Safety of Dabigatran Etexilate for Treatment of Venous Thromboembolism in Paediatric Patients Aged from Birth to < 2 Years - Results of the DIVERSITY Trial

J. Halton¹, L. Brandão², M. Luciani³, L. Bomgaars⁴, E. Chalmers⁵, L. Mitchell⁶, I. Nurmeev⁷, A. Sharathkumar⁸, P. Svirin⁹, K. Gorbatikov¹⁰, I. Tartakovsky¹¹, M. Simetzberger¹², F. Huang¹³, Z. Sun¹⁴, J. Kreuzer¹⁵, S. Gropper¹⁶, P. Reilly¹⁷, M. Brueckmann¹¹, M. Albisetti¹⁸, on Behalf of the Study Investigators
Abstract Number: PB1176

Efficacy and Safety of Fibrinogen Concentrate for On-Demand Treatment of Acute Bleeding and Surgical Prophylaxis in Pediatric Patients with Congenital Fibrinogen Deficiency: Results from the FORMA-04 Study

S.D. Lohade¹, F. D'Souza², G.S. Latha³, C. Khayat⁴, O. Zekavat⁵, B.A. Schwartz⁶, I. Kruzhkova⁷, C. Solomon⁷, S. Knaub⁷, F. Peyvandi⁸
Abstract Number: PB2520

Efficacy and Safety of Low-Molecular-Weight Heparin for the Prevention of Pregnancy-Related Recurrent Venous Thromboembolism and Obstetrical Complications

M. Abbattista¹, I. Martinelli¹, F. Gianniello¹, A. Artoni¹, P. Bucciarelli¹, M. Capecchi², F. Peyvandi²
Abstract Number: PB2361

Efficacy and Safety of Pre-Operative Insertion of Inferior Vena Cava Filter in Patients Undergoing Bariatric Surgery: A Systematic Review

R. Ikesaka¹, B. Kaur², M. Crowther¹, A. Rajasekhar³
Abstract Number: PB0155

Efficacy and Safety of Prothrombin Complex Concentrate in Obstetric Hemorrhage

A. Ronenson¹, E. Shifman², A. Kulikov³
Abstract Number: PB1336

Efficacy and Safety of Romiplostim in Children with Chronic and Persistent Immune Thrombocytopenic Purpura

M. Bordbar, M. Karimi
Abstract Number: PB2247

Efficacy and Safety Profile of Direct Oral Anticoagulants in Consecutive Patients with Severe Hereditary Thrombophilia: A Single-centre Cohort Study

E. Campello¹, C. Simion¹, L. Spiezia¹, D. Tormene¹, G. Camporese², G. Saggiorato¹, F. Dalla Valle¹, P. Simioni¹
Abstract Number: PB0921

Efficacy and Target Joint Resolution with Pharmacokinetic-Guided Rurioctocog Alfa Pegol Prophylaxis Targeting Two Factor VIII trough Levels in Patients with Severe Hemophilia A: Post-Hoc Analysis of the Phase 3 PROPEL Trial

P. Collins¹, J. Windyga², M. Escobar³, H.M. Ibrahim⁴, J.C.M. Lam⁵, S.D. Tangada⁶, W. Engl⁷, I. Honauer⁸, A. Fernandez⁸, H.-Y. Lee⁸, R. Klamroth⁹, C. Escuriola-Ettingshausen¹⁰
Abstract Number: PB1392

Efficacy of Antiplatelet Therapy in Patients with Acute Ischemic Stroke Treated with Acetylsalicylic Acid

L. Bultasova¹, Z. Hajsmanova¹, P. Sigutova¹, V. Rohan², J. Polivka²
Abstract Number: PB1500

Efficacy of Novoseven in the Treatment of Bleeding Episodes During Glanzmann´s Thrombasthenia

R. Messaoudi, Z.Zouaoui , H.Touhami
Abstract Number: PB1023

Efficacy of Platelet-rich Plasma in the Treatment of Hemophilic Arthropathy

P. Eshghi¹, F. Malek¹, B. Habibpanah¹, H. Davoudabadifarahani²
Abstract Number: PB1877

Efficacy of Preemptive Subcutaneous Rituximab in Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Study of 12 Cases

M. Delrue^1,2, M.-T. Baylatry³, A.-C. Joly³, Z. Mmarjanovic³, N. El-Khoury-Hanna⁴, F. Feger⁵, A. Veyradier^1,2, A. Stepanian^1,2, P. Coppo^6,7
Abstract Number: PB2095

Efficacy of Primary Thromboprophylaxis Agents (PTA) in Multiple Myeloma (MM) Treated with Immunomodulators (IMiD): A Network Meta-Analysis

P.A. Haddad, D. Hammoud, K. Gallagher
Abstract Number: PB2458

Efficacy of Reversible Factor Xa Inhibitors is Related to the Level of Factor VIII: Best Practice is Adjustment of the Dose for Factor VIII Level?

C. Kluft, S. Talens
Abstract Number: PB2527

Efficiency of Inhibition of Thrombin Generation and Stimulation of Fibrinolysis in vitro Fertilization Programs

M. Nikolaeva^1,2, A. Momot^1,2
Abstract Number: PB0730

Eight Succesfull Pregnancies in Patients with Congenital Fibrinogen Disorders – Single Centre Study

V. Pohlreichová, I. Čapová, V. Geierová, J. Loužil, E. Ceznerová, R. Kotlín, I. Hrachovinová, P. Salaj
Abstract Number: PB0914

Elbow Embolization for Recurrent Massive Hemarthrosis: A Case Series with Successful Outcome

S.M. Siboni¹, R. Gualtierotti², S. Braham¹, M.E. Mancuso¹, E. Biguzzi¹, A. Nicolini³, F. Peyvandi^1,2
Abstract Number: PB1222

Elderly Patients with Atrial Fibrillation Have Higher Risk of Geriatric Syndromes: Results of the Nursing Study

I. Tsareva, N. Vorobyeva, G. Semochkina, Y. Kotovskaya, O. Tkacheva
Abstract Number: PB1322

Elevated BAFF Promote B Cell Survival and Autoantibody Production through Upregulating Let-7b in Immune thrombocytopenia

Y. He, B. Zuo, C. Ruan
Abstract Number: PB/LB01

Elevated BAFF Promote B Cell Survival and Autoantibody Production through Upregulating let-7b in Immune Thrombocytopenia

Y. He
Abstract Number: PB/CO19

Elevated D-dimers Useful Prediction of Pulmonary Artery Thrombosis in COVID-19 Patients at Initial Presentation to Hospital

A. Perera¹, P. Chowdary², J. Johnson¹, L. Lamb^3,4, A. Drebes², N. Mir⁵, T. Sood¹
Abstract Number: PB0114

Elevated Levels of Activated Factor XII Are Associated with an Increased Risk of Atherothrombotic Events in Peripheral Artery Disease

B. Kremers¹, B. Mees², J.-W. Daemen², R. van Oerle¹, H. ten Cate^1,3,4, A.J. ten Cate-Hoek^1,4, H. Spronk¹
Abstract Number: PB0771

Elevated Levels of Circulating Markers of Neutrophil Extracellular Traps (NETs) Are Associated with Unfavorable Outcomes in Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis

R. Orbán-Kálmándi¹, F. Sarkady¹, I. Szegedi², I. Fekete², K. Fekete², L. Csiba², Z. Bagoly^1,3
Abstract Number: PB2138

Elevated Plasma Factor VIII Levels Are Associated with Hypercoagulability and Shorter Survival in Patients with Non-Hodgkin Lymphoma

C. Moonla^1,2, B. Akkawat^1,2, A. Sukperm^1,2, M. Meesanun^1,2, R. Jantasing^1,2, T. Chiasakul^1,2, N. Uaprasert^1,2, P. Rojnuckarin^1,2
Abstract Number: PB1971

Elevated Plasminogen Activator Inhibitor Type-1 and Soluble Thrombomodulin of Type 2 Diabetes Mellitus Subjects with Increasing Loss of Glycemic Control in Calabar, Southern Nigeria

M.S. Edem¹, E.C. Akwiwu², J.O. Akpotuzor²
Abstract Number: PB2108

Elevated Von Willebrand Factor Antigen and Activity Levels Are Risk Factors for Predicting Thrombosis in Cancer

B. Yan¹, W. Du¹, T. Hu¹, Y. Zhao², C. Ruan²
Abstract Number: PB2264

Elevated von Willebrand Factor Antigen Levels and Ristocetin Cofactor Activity are Risk Factors in Predicting Deep Vein Thrombosis

Y. Zhao, X. Zhu, Y. Song, C. Ruan
Abstract Number: PB0847

ELISA-based Quantification of intracellular FVIII Protein in IPS Derived Vascular Endothelial Cells from HA-patients with Nonsense Mutations

H. Singer, K.J. Czogalla, M. Rath, R. Al-Rifai, M. Jamil, O. El-Maarri, J. Oldenburg
Abstract Number: PB1341

Eltrombopag Suppresses Excessive Inflammation in Hepatitis B-Related Immunologic Thrombocytopenia through Inhibition of Toll-Like Receptor 4 Signaling Pathway

C. Zhang, S. Ma, J. Peng
Abstract Number: PB1355

Eltrombopag Therapy in Pediatric Acute and Chronic Immune Thrombocytopenia

M. Azizoğlu, E. Zengin, S. Aylan, Gelen, N. Sarper
Abstract Number: PB2068

Emergency Room Access of Patients on DOACs: A Six Years Single Center Experience

L. Crippa¹, L. Pozzi², L. Tomassini¹, P. Della Valle¹, E. Pattarini³, A. Fattorini¹, A. D'Angelo¹
Abstract Number: PB1652

Emerging Roles of CLEC-2 during Development of Monocrotaline-Induced Liver Injury in Mice

S. Otake¹, T. Shirai², N. Tsukiji², T. Sasaki², K. Takano³, Y. Ozaki⁴, K. Suzuki-Inoue^1,2
Abstract Number: PB0977

Emicizumab and Surgery in Severe Haemophilia A with Inhibitor: Our First Experience

V. Selvaratnam, F. Rui Jeat, Y. Yee Yee, J. Sathar
Abstract Number: PB1164

Emicizumab beyond Annualized Bleeding Rate: Do Laboratory Assays Help Predict Emicizumab Effects?

G. Moyer, B.B. Warren, L. Jacobson, C.H. Baird, D. Thornhill, J. Smith, C. Ng, T.W. Buckner, B. Branchford, M. Wang, M.J. Manco-Johnson
Abstract Number: PB1165

Emicizumab beyond Annualized Bleeding Rate: How Does Emicizumab Affect Bone Biomarkers?

B. Warren¹, J. Taylor², B. Branchford¹, C. Ng¹, D. Ambruso¹, N. Briones¹, A. Tran¹, L. Jacobson¹, D. Thornhill¹, G. Moyer¹, K. Norton¹, T.W. Buckner¹, M. Wang¹, M.J. Manco-Johnson¹
Abstract Number: PB0915

Emicizumab Concentration in Children: A Single Centre Real World Experience

D. Gosrani¹, C. Burgess², F. Alaoye², A. Taylor¹, K. Sibson¹, S. Badle¹, A. Barrie¹, J. Efford¹, J. Spires¹, M. Mathias¹, R. Liesner¹
Abstract Number: PB0784

Emicizumab for the Treatment of Acquired Hemophilia A

P. Knoebl¹, W. Sperr¹, P. Jilma², P. Quehenberger², K. Gleixner¹
Abstract Number: PB1141

Emicizumab in the Management of Hemophilia A: Real World Experience in East Malaysia

A.S.O. Tang¹, S.T. Yeo², X.Y. Tan³, C.T. Ko⁴, L.P. Chew⁵
Abstract Number: PB0822

Emicizumab Prophylactic Therapy in Patients with Hemophilia A Is Better Measured by Thrombin Generation Assay Than Thromboelastography

E.J. Martin¹, J.G. Kuhn², D.F. Brophy¹
Abstract Number: PB1081

Emicizumab Prophylaxis in a Racially Diverse Pediatric Population with Hemophilia A with and without Inhibitors

J. Garcia, A. Zia
Abstract Number: PB0323

Emicizumab Treatment in Pediatric Patients with Hemophilia A without Inhibitors: A Single-Institution Study

M. Mori¹, C. Nagae², Y. Umezawa², A. Sudo², T. Ashikaga², A. Yamashita¹, M. Taki¹
Abstract Number: PB1161

Emicizumab, beyond Annualized Bleeding Rates: Real World Joint Health and Physical Activity Data

B.B. Warren, D. Thornhill, J. Smith, R. Shearer, G. Moyer, L. Fox, M. O'Connell, R. Horton, S. Funk, A. Chan, E. Gibson, C. Ng, T.W. Buckner, B. Branchford, M.J. Manco-Johnson, M. Wang
Abstract Number: PB2427

EmpoderACO: Elaboration and Validation of a Protocol for Behavioral Change in Patients on Warfarin

H.C. Barbosa¹, A.S. Pagano², I.A. Reis³, M.F.d.S. Praxedes⁴, J.M. Da Costa⁵, H.D.C. Torres⁶, M.A.P. Martins^1,5
Abstract Number: PB2125

Empowering Cancer Patients for Non-Pharmacological Primary Prevention and Early Recognition of Cancer-Associated Thrombosis (CAT): The EMPATIC-CP Survey

M. Merino¹, E. Colomé¹, F. Esposito², C. Beato³, A. Araújo⁴, Y. De Miguel¹, C. Font²
Abstract Number: PB0178

Endocytosis of Factor VIII by Human Dendritic Cells in the Presence of Anti-Factor VIII Antibodies from Patients with Hemophilia A

M. Bou Jaoudeh^1,2, A. Mimoun^1,2, V. Daventure², S. Delignat², S. Lacroix-Desmazes²
Abstract Number: PB0076

Endogenous PCSK9 Is Related to Circulating CD34^bright/CD146^– Cells in Patients with Type 2 Diabetes Mellitus

R. Tripaldi¹, P.G.M. Simeone¹, P. Lanuti¹, R. Liani¹, S. Ciotti¹, F. Cipollone², M. Marchisio¹, F. Santilli¹
Abstract Number: PB1982

Endothelial Protein C Receptor Signaling via Protease-activated Receptor 1 Promotes Neovascularization after Ischemia in Mice

M. Bochenek^1,2, R. Gogiraju², J. Orth², S. Großmann², S. Reyda¹, H. Spronk³, T. Münzel², J. Griffin⁴, W. Ruf^1,5, K. Schäfer²
Abstract Number: PB0866

Endothelial Specific Isoform of Type XVIII Collagen (COL-18N): A Marker of Vascular Integrity in Hemophilic Arthropathy

N. Abdelhafez¹, A. Abdel Gawad Tantawy¹, N. Ahmad Safwat², K. Anwar El Sayed El Seteha³
Abstract Number: PB1127

Endovascular Abdominal Aortic Aneurysm Repair in a Mild Haemophilia A Patient: A Case Report

M. Rodriguez Lopez, E. Lopez Ansoar, A. Nieto Vazquez, C. Albo Lopez
Abstract Number: PB2212

Endovascular Management with Iliofemoral Stenting in a Patient with Chronic Venous Occlusive Disease and Antiphospholipid Antibodies

F. Piovella¹, D.I. Iosub², O. Maleti³, M. Lugli³
Abstract Number: PB0490

Enhancing Transfusable Platelets Using mRNA Therapy to Produce Exogenous Proteins

J. Leung^1,2, A. Hagner³, D. Witzigmann¹, P. Zandstra^2,3, P. Cullis¹, C. Kastrup^1,2
Abstract Number: PB2307

Epidemiologic Study of Patients with Thrombotic Events Referred to Tertiary Hospital in Southern Iran

A. Akbari¹, S. Haghpanah², H. Barzegar², A. Afrasiabi¹, S. Parand², M. Karimi²
Abstract Number: PB2250

Epidemiology and Clinicopathology of Latent versus Active JAK2-Myeloproliferative Neoplasms (MPN) in Splanchnic Venous Thrombosis

P.A. Haddad, D. Hammoud, K. Gallagher
Abstract Number: PB2347

Epidemiology and Risk Factors for Thrombosis in Pregnancy and Puerperium. Experience in One Reference Center in Mexico

E. Rojas-Zaldivar¹, E.E. Fernández-Velázquez², G.A. Altamirano-Solórzano¹, Á. Cabrera-García³
Abstract Number: PB1980

Epigenetic Regulation of Endothelial Dysfunction in Venous Thromboembolism

M. Pilard, S. Robin, F. Couturaud, C. Lemarie
Abstract Number: PB1629

Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity

A. Aliotta, D. Bertaggia Calderara, M.G. Zermatten, L. Alberio
Abstract Number: PB1603

Essential Thrombocythemia (ET): A Study of Clinical Features and Treatment Outcome in Pediatric Patients at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

M. Ameen¹, A. Almusa², K. Sidiqui², M. Alsaleh³, A. Aljefri³
Abstract Number: PB2257

Essential Thrombocythemia Complicated with Portal Vein Thrombosis and Liver Cirrhosis – A Case Report

N. Petkova¹, R. Hristoskova², D. Danchev³, I. Nikolov¹, J. Raynov¹
Abstract Number: PB0538

Establishing an External Quality Assessment Scheme (EQAS) for D-Dimer Assay in India: Results from a Pilot

S. Nair¹, V. Gupta¹, S. John¹, S. Singh¹, T. Geevar¹, S. Bala¹, J. Mammen¹, A. Srivastava²
Abstract Number: PB1574

Establishing Reference Intervals for von Willebrand Factor Multimers

M. Pikta^1,2, M. Vasse³, S. Lejniece^4,5, K.J. Smock^6,7, K.A. Moser^6,7, H. Bautista⁸, G. Nouadje⁸, V. Banys⁹
Abstract Number: PB0646

Establishing Reference Range and Validating Precision Performance of the TES-6s System

M.Y. Lee¹, S. Jang², C.-J. Park², Y.-U. Cho²
Abstract Number: PB0514

Establishment of a Novel Mixing Test Using Activated Partial Thromboplastin Time (aPTT)-Based Clot Waveform Analysis

N. Shimonishi¹, K. Nogami¹, K. Ogiwara¹, Y. Oda², T. Kawabe², M. Emmi², M. Shima¹
Abstract Number: PB0682

Establishment of Reference Intervals for Automated Light Transmission Aggregometry

D. Coen Herak¹, M. Dolcic², T. Herceg Brlek³, M. Milos¹, I. Lapic¹, R. Zadro^1,4
Abstract Number: PB0521

Estimation and Analysis of Measurement Uncertainty Acceptability: The Interest of Bayesian Inference

F. Sobas¹, K. Bourazas², M.O. Geay³, M. Beghin⁴, E. Jousselme⁵, C. Nougier⁵, P. Tsiamyrtzis⁶
Abstract Number: PB2434

ETNA VTE Europe: A Contemporary Snapshot of VTE Patients Treated with Edoxaban in Clinical Practice across Eight European Countries

A.T. Cohen¹, U. Hoffmann², P. Hainaut³, S. Gaine⁴, C. Ay⁵, M. Coppens⁶, M. Schindewolf⁷, D. Jimenez⁸, B. Brüggenjürgen⁹, P. Levy¹⁰, P. Bramlage¹¹, G. Agnelli¹²
Abstract Number: PB2432

ETNA-VTE Europe: The Effect of Body Mass Index on 12-Month Outcomes in VTE Patients with Edoxaban

M. Schindewolf¹, B. Brüggenjürgen², C. Ay³, P. Hainaut⁴, U. Hoffmann⁵, S. Gaine⁶, M. Coppens⁷, D. Jiménez⁸, P. Levy⁹, J. López Bastida¹⁰, E. Vicaut¹¹, P. Bramlage¹², G. Agnelli¹³, A.T. Cohen¹⁴, ETNA-VTE-Europe Investigators
Abstract Number: PB2478

ETNA-VTE Global: Evaluation of Bleeding Risk Based on VTE-BLEED Score on 12-month Outcomes in a Population Treated with Edoxaban

A. Cohen¹, M. Unverdorben², C. Chen², P. Reimitz³, D. Jiménez^4,5, G. Agnelli⁶
Abstract Number: PB1424

Evaluation of 4T Probability Scores, Heparin PF4 Antibody, and Serotonin Release Values in End Stage Renal Disease Patients in the Assessment of Heparin Induced Thrombocytopenia

J. Kelly¹, J. Rimsans¹, K. Sylvester¹, C. Ting¹, T. Bernier¹, J.M. Connors²
Abstract Number: PB1679

Evaluation of a New Agonist (ADP-HS^®) for Platelet Function Testing with Light Transmittance Aggregometry: A Bi-Center Study

M. Neuwirth^1,2, S. Ambard³, P. Ohlmann⁴, M. Delrue^1,5, N. Itzhar-Baïkian¹, P. Gaussem^2,6, V. Siguret^1,2, M.-C. Alessi^3,7,8, A. Stepanian^1,5
Abstract Number: PB0577

Evaluation of a New Benzylsulfonyl-D-Arg-Pro-4-Amidinobenzylamide (BAPA) Blood Collection Tube for Platelet Function Studies

J. Dahlen¹, K. Bliden², U. Tantry², P. Gurbel², K. Dobashi³, K. Hosokawa³
Abstract Number: PB0665

Evaluation of a New Device to Remove Direct Oral Anticoagulants (DOACs) from Plasma Samples

P.O. Sevenet¹, T. Hervé¹, A. Carlo¹, O. Mathieu²
Abstract Number: PB1888

Evaluation of a Rapid, Automated Chemiluminescent ADAMTS-13 Activity Assay for the ACL AcuStar

R.E. Fretwell, T. Pitchford, S. Cooper, S. Kitchen
Abstract Number: PB1850

Evaluation of Analyser Flag ´Abnormal Platelet Distribution´ in Routine Complete Blood Count (CBC)

F. Kamal
Abstract Number: PB0080

Evaluation of Biological Effects of Airborne / Urban Pollution Particles

C. Kluft, K. van Leuven
Abstract Number: PB0911

Evaluation of Bleeding in Haemophilia Carriers by ISTH-BAT: A Single Center Experience

M. Mortarino¹, S.M. Siboni¹, I. Garagiola¹, M. Boscarino¹, F. Peyvandi²
Abstract Number: PB1565

Evaluation of Carriers of Type 3 von Willebrand Disease with PFA200

T. Geevar¹, R. Gautam Dave¹, S. Singh¹, R. V¹, F. N A², A. Srivastava², S. C Nair¹
Abstract Number: PB0341

Evaluation of Coagulation FIX Binding to Collagen IV and the Impact on Thrombin Generation

G.B. Morrow¹, M.A. Laffan², N. Curry^1,3
Abstract Number: PB1398

Evaluation of Dual Antiplatelet Therapy Combining Aspirin and Clopidogrel for Intracranial Stenting Procedures: A Retrospective Single Center Study

L. Goncalves, D. Goncalves, C. Monteiro, C. Koch
Abstract Number: PB0597

Evaluation of EQA Material on Lumira Dx Point of Care Platform: UK NEQAS for Blood Coagulation Study

L. Brown, D. Kitchen, I. Jennings, S. Kitchen, A. Lowe, S. Munroe - Peart, I. Walker
Abstract Number: PB0908

Evaluation of Factors Associated with Extended Half-Life Product Utilization for Men with Hemophilia B Participating in the Community Counts Registry from 2014-2018

F. Bethea¹, C. Kempton², M. Hayat³
Abstract Number: PB0967

Evaluation of Factors Associated with Prophylaxis Treatment Regimen among Men with Hemophilia B Participating in the Community Counts Registry from 2014-2018

F. Bethea¹, C. Kempton², M. Hayat³
Abstract Number: PB1409

Evaluation of Fondaparinux (Arixtra®) at a Large Academic Medical Center

K. Marsh, K. Sessa, Q. Huynh, J. Papadopoulos, D. Green, T. Ahuja
Abstract Number: PB0433

Evaluation of Global Coagulation Assays in Pregnancy

D. O'Keefe¹, H. Nandurkar², P. Ho³, L. Hui¹, H.Y. Lim^2,3,4
Abstract Number: PB0628

Evaluation of Hemostatic Markers in Patients with Sickle Cell Disease Using or Not Hydroxyurea

S.L. Toledo¹, M. Oliveira¹, L. Ferreira¹, V.S. Ladeira², M.D.G. Carvalho³, L.M. Dusse³, D.R. Rios¹, M. Pinheiro¹
Abstract Number: PB0631

Evaluation of IgG4 ELISA for the Screening of Factor VIII Inhibitors in Hemophilia A

N. Awasthi¹, K. Riaz¹, V. Tiwari², S. Arshad¹, N. Husain¹
Abstract Number: PB1066

Evaluation of Inhibitor Risk Prediction Tools Based on Genetic Risk Factors in Persons with Hemophilia A

A.B. Payne¹, C.H. Miller¹, D. Ellingsen¹, J. Driggers¹, C.J. Bean¹, J.G. Mulle^2,3, J.M. Soucie¹, Hemophilia Inhibitor Research Study Investigators
Abstract Number: PB0620

Evaluation of INR and APTTs Using the Q Family of Analysers in Comparison to ACL TOP

A. Woolley, K. Hickey, M. Bryant, L. Marley, S. Kitchen
Abstract Number: PB0841

Evaluation of Intron 22 and Intron 1 Inversions of Factor VIII Gene in Haemophilia A Patients

I. Khuwaja¹, I.D. Ujjan¹, A. Naz², K. Aamir¹
Abstract Number: PB0447

Evaluation of Plasma Level of Soluble CLEC2, a Novel Platelet Activation Marker, in Patients with Sepsis Induced Coagulopathy -A Pilot Study

H. Ishikura¹, Y. Irie¹, K. Hoshino¹, J. Maruyama¹, M. Nakashio¹, M. Kawamura², K. Suzuki-Inoue³
Abstract Number: PB1628

Evaluation of Platelet Count and Platelet Indices of Male Cannabis Sativa (Marijuana) Consumers in Calabar South, Cross River State, Nigeria

D.C. Okpokam¹, M. Nsonko², A.O. Obembe²
Abstract Number: PB2221

Evaluation of Platelet Indices in Patients with Splanchnic Vein Thrombosis

N. Kumar¹, S. Sharma¹, I. Bihana¹, V. Uppal¹, J. Ahluwalia¹, N. Varma¹, S. Naseem¹, S.K. Sinha²
Abstract Number: PB1403

Evaluation of Platelet Reactivity in Pediatric Patient on Dual Antiplatelet Therapy after Stent Implantation of Ductus Arteriosus: A Case Report

D. Dineva¹, E. Doncheva¹, E. Levunlieva²
Abstract Number: OC 11.4

Evaluation of Platelets Activation and Fibrin Clotting in Post-Menopausal Women with Takotsubo Syndrome

P. Amadio, S.S. Barbieri, B. Porro, S. Eligini, V. Cavalca, S. Barbieri, P.J. Werba, P. Olivares, F. Veglia, E. Tremoli, D. Trabattoni
Abstract Number: PB0335

Evaluation of Structurally Altered Protein in Factor VIII Therapeutic Products Using Chromatography on Immobilized von Willebrand Factor

H. Chun, J. Pettersson, S. Shestopal, E. Marakasova, T. Lee, A. Sarafanov
Abstract Number: PB0449

Evaluation of the Accuracy of INR Values Measured by a POCT System in a German Clinic with Patients Taking Phenprocoumon as VKA Therapy

H. Voller^1,2, J. Ellis³, J. Loecherbach³
Abstract Number: PB0657

Evaluation of the Atellica® COAG 360 (Siemens Healthineers) at Caen-Normandy University Hospital (FRANCE)

B. Leroy, M. Brionne-Francois, S. Mesnard, M. Gavard, Y. Repesse
Abstract Number: PB0172

Evaluation of the CEPHEN Reagent for the Determination of Activated Partial Thromboplastin Time in Current Practice

I. Martin-Toutain¹, K. Lfadeli¹, F. Corre¹, M. Lejeune¹, G. Nguyen¹, J.-P. Delorme², Y. Bourti², C. Frere^1,3
Abstract Number: PB0342

Evaluation of the Effect Emicizumab Neutralizing Antibodies on aPTT Clotting-based Tests Results in Patients Treated with Emicizumab

C. Novembrino¹, M. Boscolo-Anzoletti¹, F. Rossi¹, E. Mancuso¹, S. Shinohara², F. Peyvandi^1,3
Abstract Number: PB0516

Evaluation of the Newly-developed Collagen Induced Platelet Aggregation Level (CPAL) System in Aggregometer on Automated Coagulation Analyzer

K. Kitano¹, K. Uematsu^2,3, T. Sakayori¹, Y. Omori⁴, H. Ishida⁴, N. Arai¹, H. Matsubara³, Y. Komiyama⁵, Y. Enomoto³
Abstract Number: PB1175

Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System (T-TAS) in Comparison to the Platelet Function Analyzer (PFA) in Subjects with Primary Hemostatic Defects

J. Charpy¹, N. Benattar², P.-E. Chaghouri¹, S.-M. Castet³, Y. Huguenin³, C. James¹, M. Fiore⁴
Abstract Number: PB0037

Evaluation of the Selectivity of BCR-ABL Tyrosine Kinase Inhibitors (TKIs): A Systematic Review

H. Haguet¹, C. Challe², Y. Nezzar², F. Mullier³, C. Graux³, J.-M. Dogné¹, J. Douxfils^1,4
Abstract Number: PB1213

Evaluation of the Skeletal Lesions in the Lebanese Patients with Afibrinogenemia

C. Djambas Khayat¹, T. Younane²
Abstract Number: PB0627

Evaluation of the Succeeder SF-8200 Fully Automated Coagulation Analyzer

O. Zengi, A. Kirankaya, S.H. Kucuk, T. Sarac
Abstract Number: PB2428

Evaluation of Thrombin and Fibrin Generation in Venous Thromboembolism (VTE) Patients Receiving Anticoagulation

J. Wang^1,2, H.Y. Lim^1,2, R. Brook¹, O. Aswapanyawongse², P. Ho^1,2
Abstract Number: PB1375

Evaluation of Thrombocytopenia and Fetomaternal Outcome in Pregnancy at a Tertiary Care Hospital

K. Aamir¹, I. Ujjan¹, A. Naz²
Abstract Number: PB0640

Evaluation of Thrombogenicity of Apheresis-collected Platelet Concentrates under Blood Flow Condition

T. Nagasato¹, T. Ohnishi-Wada¹, H. Sameshima-Kaneko¹, C. Oyamada¹, K. Hosokawa¹, Y. Matsubara²
Abstract Number: PB0476

Evaluation of Thrombomodulin Levels in Women with Breast Cancer Undergoing Doxorubicin Treatment

M. Teodoro Alves Vieira¹, R. Simões², L.M. Silva³, H.H. Oliveira³, I.D. Souza¹, M.D.G. Carvalho¹, L.M. Dusse¹, A.D.P. Sabino¹, R.M. Pestana¹, K.B. Borges¹
Abstract Number: PB0255

Evolutionary History of the Kallikrein-Kinin System and Factor XI

M. Ponczek¹, C. Kastrup², A. Shamanaev³, K. Dickeson⁴, B.M. Mohammed⁴, A.R. LaPlace⁴, M.-F. Sun⁴, Q. Cheng⁴, A. Gruber⁵, J. Emsley⁶, D. Gailani⁴
Abstract Number: PB0817

Examining the Hemophilia Disability Paradox

D. Nugent¹, J. O'Hara², A. Martin³, G. Morgan³, T. Buckner⁴, M. Skinner^5,6, B. O'Mahony^7,8, B. Mulhern⁹, E.K. Sawyer¹⁰, N. Li¹⁰
Abstract Number: PB1526

Excessive Angiogenesis in von Willebrand Factor Knockout Mice is Accompanied by Increased Perivascular Coverage of Neovessels

L. Sommerville¹, J. Xu¹, D. Monroe², M. Hoffman^1,3
Abstract Number: PB0611

Excluding Anticoagulants and Antiplatelet Drugs with Rotational Thromboelastometry

A.-M. Hulshof, R. Olie, M. Vries, P. Verhezen, R. Wetzels, H. ten Cate, Y. Henskens
Abstract Number: PB1627

Exercise Training Enhances Mitochondrial Bioenergetics of Platelets in Patients with Peripheral Arterial Disease

J.-S. Wang
Abstract Number: OC 05.4

Exogenous Microparticles Bearing Tissue Factor Improve Outcome After Collagenase-Induced Intracranial Hemorrhage

F. Potzeha, M. Yetim, D. Vivien, T. Gaberel, M. Gauberti, S. Martinez de Lizarrondo
Abstract Number: PB0500

Exome-array Analysis of Plasma Hemostatic Factors D-dimer, tPA and PAI-1 Identifies Novel Genes

F. Thibord¹, C. Song¹, M.-H. Chen¹, B.A.T. Rodriguez¹, L.R. Yanek², M. Sabater-Lleal³, G.D. Carrasquilla⁴, L. Hampton⁵, J.I. Rotter⁶, K.C. Desch⁷, P. Morange⁸, M.E. Kleber⁹, N.L. Smith¹⁰, A.C. Morrison¹¹, A.D. Johnson¹
Abstract Number: PB1293

Expanding the Spectrum of Heterozygous Antithrombin Deficiency Type II HBS? Unusual Presentation of Thromboembolic Events in Two Children

K. Beutel¹, S. Liptay¹, C. Makowski¹, S. Eber^1,2, M.-M. Steinborn³
Abstract Number: PB1099

Expectations and Concerns of Patients with Haemophilia towards Gene Therapy – Results of Patients and Expert Focus Groups

S. von Mackensen
Abstract Number: PB0790

Experience with Recombinant Porcine FVIII in Patients with Acquired Factor VIII Deficiency Undergoing Major Surgery

M. Escobar, N. Montanez, I. Aboshady, K. Chong
Abstract Number: PB1527

Explanations for Rise of Levels of Factor VIII and von Willebrand Factor Antigen with Age

E. Biguzzi^1,2, F. Castelli¹, W.M. Lijfering¹, S.C. Cannegieter¹, J. Eikenboom³, F.R. Rosendaal¹, A. van Hylckama Vlieg¹
Abstract Number: PB1861

Exploration of Coagulation Disorders, von Willebrand Factor and ADAMTS13 in a Cohort of 45 Patients with Hemophagocytic Lymphohistiocytosis

A. Launois^1,2, S. Valade³, E. Roose⁴, E. Mariotte³, M. Darmon³, L. Galicier⁵, L. Zafrani³, V. Lemiale³, E. Azoulay³, S. Mathis⁶, I. Kalidi⁶, A. Stepanian^1,2, K. Vanhoorelbeke⁴, A. Veyradier^1,2, B. Joly^1,2
Abstract Number: PB2201

Exploring Alternative Approaches of Using the Villalta Scale to Capture the Post-Thrombotic Syndrome: A Sub-analysis of the ATTRACT Trial

S.R. Kahn¹, C.-S. Gu², J.-P. Galanaud³, C. Kearon⁴, S. Vedantham⁵, for the ATTRACT Trial
Abstract Number: PB1105

Exploring RNA Editing System as Innovative Correction Strategy for Hemophilia A

S. Pignani, G. Roman, S. Buzzi, G.E. Walker, A. Follenzi
Abstract Number: PB0404

Exploring the Effectiveness of DNA and Glycosaminoglycans as Inhibitors of Histones

N. Sharma, L. Haggstrom, S. Sohrabipour, D.J. Dwivedi, P.C. Liaw
Abstract Number: PB0813

Exploring the Relationship between Common Complications of Haemophilia and Anxiety and Depression in People with Haemophilia A

T. Burke^1,2, E. Ferri Grazzi^1,2, A. Shaikh^1,2, C. Hawes³, C. Camp³, J. O'Hara^1,2
Abstract Number: PB0804

Exploring the Relationship between Condition Severity and Health-Related Quality of Life in Haemophilia A

T. Burke^1,2, E. Ferri Grazzi^1,2, A. Shaikh^1,2, C. Hawes³, C. Camp³, J. O'Hara^1,2
Abstract Number: PB0375

Expression of Circulating Microparticles Procoagulant Activity in Cirrhotic Patients

B. Mejda¹, B. Hela¹, B. Dhouha¹, L. Asma², J. Boubaker², B.R. Neila¹
Abstract Number: PB1956

Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes

N. Ziliotto¹, G. Marchetti², S. Meneghetti¹, E. Menegatti³, M. Baroni¹, B. Lunghi¹, F. Salvi⁴, M. Ferracin⁵, A. Branchini¹, D. Gemmati², F. Mascoli⁶, P. Zamboni³, F. Bernardi¹
Abstract Number: PB1132

Extended Half-life FIX and Disruptive Therapies in Carriers with FVIII and FIX Deficiencies: Preliminary Experience

C. Hermans, C. Lambert
Abstract Number: PB0890

Extended Half-Life of the Double-Chain Recombinant Factor VIII-Fc Fusion Protein (FRSW107) in Previous Treated Hemophilia A Patients

F. Xue¹, Y. Chen², Q. Wen², J. Sun³, C. Xu³, X. Zhang⁴, H. Sun¹, Y. Wang², H. Su⁵, R. Yang¹
Abstract Number: PB2455

Extended Treatment in Unprovoked Venous Thromboembolism: What Is Important to Patients?

A. van de Brug, M.A. de Winter, H.A.H. Kaasjager, M. Nijkeuter
Abstract Number: PB0453

Extensive Characterization of the Hemostatic Changes during Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Carcinomatosis

P. Gomez Rosas^1,2, N.F.J. Schillaci¹, M. Marchetti¹, L. Russo¹, S. Gamba¹, C. Verzeroli¹, C. Giaccherini¹, C.J. Tartari¹, A. Vignoli¹, S. Magnone³, A. Falanga^1,4
Abstract Number: PB0533

Extensive Experiments in (Un)Diagnosed Bleeding Patients with Prolonged Platelet Function Analyser Closure Times

F. Heubel-Moenen¹, F. Swieringa², L. Herfs³, M. Sims⁴, K. Downes⁴, D. Greene⁴, R. Wetzels⁵, P. Verhezen⁵, P. Machiels³, W. Ouwehand⁶, J. Heemskerk², E. Beckers¹, Y. Henskens⁵
Abstract Number: PB0274

External Quality Assurance (EQA) for the Thromboelastometry Devices: UK NEQAS BC Programme Update

D.P. Kitchen, L. Brown, S. Munroe-Peart, A. Lowe, I. Jennings, S. Kitchen, I. Walker